Income StatementBalance SheetCash FlowSegments
Moderna logo

Moderna Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Moderna holds $11.5B in total assets. Shareholders' equity is $7.4B against $1.3B in total debt. Cash and equivalents total $1.9B. The current ratio is 2.41 and debt-to-equity is 0.179. Based on the Q1 2026 filing.

Total Assets$11.5BTotal Stockholders Equity$7.4BLong Term Debt$590.0MCash And Equivalents$1.9BTotal Current Assets$5.8BTotal Current Liabilities$2.4B
Latest FilingQ1 2026
Report Date2026-05-01
Market Cap$18.9B
ROE-36.56%

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$405.0M$226.0M$175.0M$267.0M$317.0M$161.0M
Accrued Contingent Liabilities—————$950.0M
Accrued expenses$1.4B$120.0M$197.0M$310.0M$420.0M$108.0M
Accrued Manufacturing Costs$312.0M$120.0M$197.0M$310.0M$420.0M$108.0M
Accrued Progress Collections and Price Adjustments$58.0M$58.0M$65.0M$157.0M$153.0M$154.0M
Accrued Royalties (Current)$46.0M$5.0M$6.0M$42.0M$31.0M$967.0M
Other Commercial Liabilities$1.4B$1.0B$987.0M$1.2B$1.4B$1.9B
Contract liabilities$58.0M$58.0M$65.0M$157.0M$153.0M$154.0M
Contract Liabilities and Refund Liability$370.0M$337.0M$308.0M$426.0M$509.0M$470.0M
Accrued Liabilities, Current$1.4B$1.0B$987.0M$1.2B$1.4B$1.9B
Compensation and benefits$312.0M$120.0M$197.0M$310.0M$420.0M$108.0M
Other accrued liabilities$221.0M$252.0M$192.0M$73.0M$185.0M$220.0M
Current portion of long-term debt$23.0M$28.0M$27.0M$31.0M$25.0M$31.0M
Deferred revenue$153.0M$125.0M$218.0M$163.0M$99.0M$102.0M
Finance Lease Liability, Current$23.0M———$25.0M—
Finance Lease Liability Payment Due—$67.0M$63.0M$60.0M—$46.0M
Finance Lease Liability - Undiscounted Excess Amount—$4.0M$4.0M$3.0M—$2.0M
Lease Liability Payments - 2020 (Remaining Three Months)—$47.0M$29.0M$12.0M—$47.0M
Lease Liability Payments - 2021—$24.0M$27.0M$26.0M—$20.0M
Operating Lease Liability Payments - 2024 (Lessee)—$77.0M$78.0M$78.0M—$81.0M
Operating Lease Liability Payments - 2025 (Lessee)—$82.0M$82.0M$82.0M—$80.0M
Lease Liability Payments - Due Year Two—$18.0M$20.0M$20.0M—$0.0
Lease Liability Payments - Due Year Three—$80.0M$81.0M$81.0M—$82.0M
Lease Liability Payments - Due Year Four—$82.0M$82.0M$82.0M—$80.0M
Lease Liability Payments - Remainder of Fiscal Year—$25.0M$16.0M$14.0M—$26.0M
Note payable to DIRECTV$221.0M$252.0M$192.0M$73.0M$185.0M$220.0M
Operating lease liabilities, current$14.0M$15.0M$16.0M$17.0M$17.0M$19.0M
Operating Lease Liability Payments Due—$1.1B$1.1B$1.1B—$1.0B
Operating Lease Liability - Undiscounted Excess Amount—$433.0M$423.0M$409.0M—$383.0M
Other current liabilities$23.0M$30.0M$31.0M$25.0M$16.0M$59.0M
Total current liabilities$2.2B$1.6B$1.6B$1.7B$2.0B$2.4B

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$358.0M$78.0M$36.0M$1.0B$184.0M$71.0M
Available-for-Sale Debt Securities - Amortized Cost$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Available-for-Sale Debt Securities - Fair Value by Maturity$7.6B$6.8B$6.2B$5.5B$5.5B$5.5B
Available-for-Sale Debt Securities - Single Maturity Date$7.6B$6.8B$6.2B$5.5B$5.5B$5.5B
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)$22.0M$11.0M$7.0M$5.0M$3.0M$2.0M
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)$22.0M$11.0M$7.0M$5.0M$3.0M$2.0M
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value$6.0M$2.0M$2.0M$0.0$1.0M$9.0M
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)$6.0M$2.0M$2.0M$0.0$1.0M$9.0M
Available-for-Sale Debt Securities - Unrealized Loss Position$4.3B$3.1B$2.6B$1.4B$1.2B$3.9B
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value$22.0M$11.0M$7.0M$5.0M$3.0M$2.0M
AFS and Trading Securities - Unrealized Loss Position Fair Value$28.0M$13.0M$9.0M$5.0M$4.0M$11.0M
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value$6.0M$2.0M$2.0M$0.0$1.0M$9.0M
Allowance for Doubtful Accounts$0.0—$12.0M$3.0M$3.0M$6.0M
Allowance for Doubtful Accounts Receivable (Current)$0.0—$12.0M$3.0M$3.0M$6.0M
Cash and cash equivalents$1.9B$1.6B$1.3B$1.1B$2.6B$1.9B
Cash, Cash Equivalents, and Marketable Securities$28.0M$13.0M$9.0M$5.0M$4.0M$11.0M
Available For Sale Securities Debt Securities Current$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Finished goods$28.0M$14.0M$45.0M$128.0M$33.0M$14.0M
Other current assets$38.0M$69.0M$57.0M$56.0M$45.0M$51.0M
Accrued investment income$59.0M$53.0M$47.0M$40.0M$42.0M$39.0M
Trading assets$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Income taxes receivable$28.0M$33.0M$40.0M$41.0M$41.0M$35.0M
Finished goods$28.0M$14.0M$45.0M$128.0M$33.0M$14.0M
Raw materials$63.0M$75.0M$83.0M$85.0M$91.0M$94.0M
Work in process$26.0M$39.0M$112.0M$119.0M$29.0M$38.0M
Inventories$150.0M$134.0M$127.0M$115.0M$114.0M$117.0M
Prepaid expenses and other current assets$599.0M$585.0M$764.0M$716.0M$408.0M$348.0M
Prepaid Tax$45.0M$45.0M$31.0M$35.0M$37.0M$29.0M
Restricted cash—$1.0M$1.0M$1.0M—$0.0
Short-term investments$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Total current assets$8.1B$6.8B$6.2B$6.6B$6.5B$5.8B

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Additional paid-in capital$866.0M$982.0M$1.1B$1.3B$1.4B$1.5B
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss$2.6B$1.4B$567.0M$499.0M$283.0M$271.0M
Accumulated other comprehensive income (loss)-$10.0M$10.0M$23.0M$27.0M$45.0M$25.0M
Common stock01.6B1.6B1.6B1.6B1.6B
Common Stock Par Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00
Common Stock Shares Issued386M387M389M391M394M397M
Convertible Preferred Stock Authorized Shares162M162M162M162M162M162M
Convertible Preferred Stock Issued Shares000000
Convertible Preferred Stock Outstanding Shares000000
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively$0.0$0.0$0.0$0.0$0.0$0.0
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding$0.0$0.0$0.0$0.0$0.0$0.0
Investments - Gross Unrealized Losses$28.0M$13.0M$9.0M$5.0M$4.0M$11.0M
Preferred stock$0.0$0.0$0.0$0.0$0.0$0.0
Preferred Stock Par Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00
Retained earnings$10.0B$9.1B$8.2B$8.0B$7.2B$5.9B
Share-Based Payment - Unrecognized Cost of Nonvested Awards—$1.1B$908.0M$770.0M—$978.0M
Total liabilities and stockholders' equity$14.1B$12.7B$12.0B$12.1B$12.3B$11.5B
Total stockholders' equity$10.9B$10.1B$9.4B$9.3B$8.7B$7.4B

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)$2.5B$2.4B$2.4B$2.1B$2.3B$2.3B
Allowance for credit losses$0.0$0.0$0.0$0.0$0.0$0.0
Deferred Tax Assets and Other Non-Current Assets$594.0M$556.0M$546.0M$530.0M$605.0M$675.0M
Available-for-sale securities$2.5B$2.4B$2.4B$2.1B$2.3B$2.3B
Goodwill$52.0M$52.0M$52.0M$52.0M$52.0M$52.0M
Intangible assets, net$40.0M$49.0M$48.0M$47.0M$45.0M$116.0M
Investments - Amortized Cost Basis$7.6B$6.8B$6.2B$5.5B$5.5B$5.6B
Net Investment in Lease$759.0M$752.0M$750.0M$738.0M$719.0M$706.0M
Long-term marketable securities$2.5B$2.4B$2.4B$2.1B$2.3B$2.3B
Deferred tax assets$81.0M$81.0M$81.0M$81.0M$81.0M$82.0M
Intangible assets &#8212; net$40.0M$49.0M$48.0M$47.0M$45.0M$116.0M
Operating lease right-of-use assets$759.0M$752.0M$750.0M$738.0M$719.0M$706.0M
Other non-current assets$594.0M$556.0M$546.0M$530.0M$605.0M$675.0M
Property, plant and equipment, net$2.2B$2.2B$2.2B$2.1B$2.1B$2.1B
Operating lease right-of-use assets$759.0M$752.0M$750.0M$738.0M$719.0M$706.0M
Operating Lease Right-of-Use Assets in Other Assets$759.0M$752.0M$750.0M$738.0M$719.0M$706.0M
Other non-current assets$21.0M$16.0M$22.0M$22.0M$52.0M$50.0M
Accumulated depreciation$527.0M$566.0M$623.0M$671.0M$737.0M$794.0M
Total property and equipment, gross$2.7B$2.8B$2.8B$2.8B$2.9B$2.9B
Property and equipment, net$2.2B$2.2B$2.2B$2.1B$2.1B$2.1B
Software and Technology Licenses, Net$594.0M$556.0M$546.0M$530.0M$605.0M$675.0M
Total assets$14.1B$12.7B$12.0B$12.1B$12.3B$11.5B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Components252.00180.00140.00103.00108.00292.00
Cumulative Cost Basis$7.6B$6.8B$6.2B$5.5B$5.5B$5.6B
Accounts Receivable, Chargebacks, Discounts And Fees$340.0M-$171.0M$212.0M$975.0M$181.0M$126.0M
Accounts Receivable, after Allowance for Credit Loss$358.0M$78.0M$36.0M$1.0B$184.0M$71.0M
Clinical trials$94.0M$88.0M$38.0M$30.0M$20.0M$46.0M
Commercial$45.0M$24.0M$24.0M$21.0M$23.0M$16.0M
Development operations$120.0M$120.0M$108.0M$94.0M$106.0M$81.0M
Manufacturing$109.0M$128.0M$152.0M$113.0M$140.0M$79.0M
Other external goods and services$131.0M$82.0M$63.0M$53.0M$57.0M$82.0M
Property, plant and equipment$99.0M$49.0M$47.0M$31.0M$45.0M$31.0M
Licensing Arrangements$46.0M$5.0M$6.0M$42.0M$31.0M$967.0M
Accounts Receivable, Allowance for Credit Loss$0.0—$12.0M$3.0M$3.0M$6.0M
Total$7.6B$6.8B$6.2B$5.5B$5.5B$5.6B
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five$2.5B$2.4B$2.4B$2.1B$2.3B$2.3B
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five$2.5B$2.4B$2.4B$2.1B$2.3B$2.3B
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One$5.1B$4.4B$3.9B$3.4B$3.2B$3.3B
Collaboration receivable$58.0M$26.0M$20.0M$9.0M$13.0M$1.0M
Common stock, par value (in dollars per share)$0.0$0.0$0.0$0.0$0.0$0.0
Common stock, shares authorized (in shares)$1.6B$1.6B$1.6B$1.6B$1.6B$1.6B
Common stock, shares issued (in shares)$386.0M$387.0M$389.0M$391.0M$394.0M$397.0M
Common Stock, Shares, Outstanding$386.0M$387.0M$389.0M$391.0M$394.0M$397.0M
Contract with Customer, Liability$211.0M$183.0M$283.0M$320.0M$252.0M$256.0M
Accrued sales returns$370.0M$337.0M$308.0M$426.0M$509.0M$470.0M
Debt Securities, Available-for-Sale, Allowance for Credit Loss$0.0$0.0$0.0$0.0$0.0$0.0
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss$2.6B$1.4B$567.0M$499.0M$283.0M$271.0M
Less than 12 months$6.0M$2.0M$2.0M$0.0$1.0M$9.0M
12 months or more$22.0M$11.0M$7.0M$5.0M$3.0M$2.0M
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss$1.7B$1.8B$2.0B$869.0M$931.0M$3.6B
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss$4.3B$3.1B$2.6B$1.4B$1.2B$3.9B
Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions$252.0$180.0$140.0$103.0$108.0$292.0
Debt Securities, Available-for-Sale, Unrealized Loss Position$28.0M$13.0M$9.0M$5.0M$4.0M$11.0M
Deferred income taxes$231.0M$234.0M$237.0M$239.0M$249.0M$253.0M
Down payments and prepayments, non-current$139.0M$119.0M$111.0M$105.0M$100.0M$97.0M
Unrecognized compensation cost related to non-vested awards—$1.1B$908.0M$770.0M—$978.0M
Current maturities of long-term debt$23.0M$28.0M$27.0M$31.0M$25.0M$31.0M
Finance Lease Liability Payments Due—$67.0M$63.0M$60.0M—$46.0M
2027—$24.0M$27.0M$26.0M—$20.0M
Finance Lease Liability Payments Due Year Four—$0.0$0.0$0.0—$0.0
Finance Lease Liability Payments Due Year Three—$0.0$0.0$0.0—$0.0
Finance Lease Liability Payments Due Year Two—$18.0M$20.0M$20.0M—$0.0
Thereafter—$0.0$0.0$0.0—$0.0
Finance Lease Liability Undiscounted Excess Amount—$4.0M$4.0M$3.0M—$2.0M
Finance Lease, Right-of-Use Asset, after Accumulated Amortization$65.0M$59.0M$53.0M$47.0M$42.0M$36.0M
Research and development funding receivable (Note 5)$0.0—$191.0M$195.0M$0.0$7.0M
Income Taxes Receivable Noncurrent$97.0M$99.0M$99.0M$99.0M$161.0M$161.0M
Interest receivable on interest rate and cross currency swaps$59.0M$53.0M$47.0M$40.0M$42.0M$39.0M
Loss on future firm purchase commitments$60.0M$20.0M$14.0M$12.0M$5.0M$5.0M
Lessee Operating Lease Liability Payments Due—$1.1B$1.1B$1.1B—$1.0B
Thereafter—$757.0M$762.0M$760.0M—$679.0M
Lessee Operating Lease Liability Undiscounted Excess Amount—$433.0M$423.0M$409.0M—$383.0M
Loss Contingency Accrual—————$950.0M
Number of development candidates—31.0030.0030.00—25.00
Number of development programs—41.0039.0040.00—35.00
Operating And Finance Lease, Liability$747.0M$745.0M$741.0M$734.0M$715.0M$708.0M
Operating And Finance Lease, Liability, Current$37.0M$43.0M$43.0M$48.0M$42.0M$50.0M
Operating And Finance Lease, Liability, Noncurrent$710.0M$702.0M$698.0M$686.0M$673.0M$658.0M
Operating And Finance Lease, Right-Of-Use Asset$824.0M$811.0M$803.0M$785.0M$761.0M$742.0M
Down payments and prepayments related to manufacturing and materials$106.0M$84.0M$96.0M$77.0M$61.0M$55.0M
Other$23.0M$30.0M$31.0M$25.0M$16.0M$59.0M
Other$36.0M$40.0M$39.0M$42.0M$36.0M$30.0M
Preferred Stock, Par or Stated Value Per Share$0.0$0.0$0.0$0.0$0.0$0.0
Preferred Stock, Shares Authorized$162.0M$162.0M$162.0M$162.0M$162.0M$162.0M
Preferred Stock, Shares Issued$0.0$0.0$0.0$0.0$0.0$0.0
Preferred Stock, Shares Outstanding$0.0$0.0$0.0$0.0$0.0$0.0
Raw materials$41.0M$28.0M$30.0M$46.0M$30.0M$27.0M
Estimated reimbursements to wholesalers and distributors$103.0M$179.0M$118.0M$0.0$84.0M$111.0M
Research and development funding liability (Note 5)$58.0M$0.0$0.0$0.0$43.0M$0.0
Remainder of Fiscal Year 2024—$47.0M$29.0M$12.0M—$47.0M

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Contract Liabilities, Non-Current$58.0M$58.0M$65.0M$157.0M$153.0M$154.0M
Finance lease liabilities$39.0M$35.0M$32.0M$26.0M$20.0M$13.0M
Finance Lease Liabilities (Total)$62.0M$63.0M$59.0M$57.0M$45.0M$44.0M
Operating Lease Liability Payments - 2027 (Lessee)—$80.0M$81.0M$81.0M—$82.0M
Operating Lease Liability Payments - 2028 (Lessee)—$82.0M$82.0M$82.0M—$80.0M
Long-term debt$0.0———$590.0M$590.0M
Deferred revenue, net of current portion$58.0M$58.0M$65.0M$157.0M$153.0M$154.0M
Operating lease liabilities, non-current$671.0M$667.0M$666.0M$660.0M$653.0M$645.0M
Operating Lease Liabilities (Total)$685.0M$682.0M$682.0M$677.0M$670.0M$664.0M
Other non-current liabilities$267.0M$274.0M$276.0M$281.0M$285.0M$283.0M
Total liabilities$3.2B$2.6B$2.6B$2.8B$3.7B$4.1B